Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(20):1490-1491; doi:10.1093/jnci/djh311
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Baum, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baum, M.
Related Collections
Right arrowCorrespondence about this Article
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

EDITORIAL

Breast Cancer Screening Comes Full Circle

Michael Baum

Correspondence to: Professor Michael Baum, MD, ChM, FRCS, FRCR, FRSA, University College London, London, England (e-mail:michael@mbaum.freeserve.co.uk)

The first 10% of the full text of this article appears below.

During the mid-1990s, I was invited to address the local chapter of the American Cancer Society in Miami, Florida, to talk about the British approach to mammographic screening. During my presentation, I described the tough issues of balancing the benefits for the few versus the harms for the many, and I suggested that maybe screening does not benefit the premenopausal woman at all. Despite my role in establishing the National Screening Programme when I was Chief of Surgery at King's College London in 1988, my comments were not well received, and, as the audience stormed out on me in a paroxysm of pique, I learned a painful lesson that day that some topics, particularly breast cancer screening, do not lend themselves to polite and rational scientific debate.

However, I believe that a scientific debate is highly warranted . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Correspondence about this Article

Re: Breast Cancer Screening Comes Full Circle
Stephen H. Taplin, William E. Barlow, Marianne Ulcickas-Yood, Emily Westbrook, Ann M. Geiger, Kimberley Bischoff, and Laura Ichikawa
J Natl Cancer Inst 2005 97: 461. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Br J OphthalmolHome page
R Stoutenbeek, S de Voogd, R C W Wolfs, A Hofman, P T V M de Jong, and N M Jansonius
The additional yield of a periodic screening programme for open-angle glaucoma: a population-based comparison of incident glaucoma cases detected in regular ophthalmic care with cases detected during screening
Br J Ophthalmol, September 1, 2008; 92(9): 1222 - 1226.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
W. Dong, D. A. Berry, T. B. Bevers, S.-W. Kau, L. Hsu, R. L. Theriault, and Y. Shen
Prognostic Role of Detection Method and Its Relationship with Tumor Biomarkers in Breast Cancer: The University of Texas M. D. Anderson Cancer Center Experience
Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1096 - 1103.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
S. H. Taplin, W. E. Barlow, M. Ulcickas-Yood, E. Westbrook, A. M. Geiger, K. Bischoff, and L. Ichikawa
Re: Breast Cancer Screening Comes Full Circle
J Natl Cancer Inst, March 16, 2005; 97(6): 461 - 461.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
A. S. Whittemore
Re: Reason for Late-Stage Breast Cancer: Absence of Screening or Detection, or Breakdown in Follow-Up?
J Natl Cancer Inst, March 2, 2005; 97(5): 400 - 400.
[Full Text] [PDF]